![]() | ![]() |
Formats:
|
||||||||||||||||
A REAL-TIME PCR-BASED ASSAY FOR DETECTION OF WUCHERERIA BANCROFTI DNA IN BLOOD AND MOSQUITOES Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri; Research & Training Center on Vectors of Diseases, Ain Shams University, Cairo, Egypt; Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea; Department of Biological Sciences, Smith College, Northampton, Massachusetts * Address correspondence to R. U. Rao, Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, Box 8051, 660 S Euclid Avenue, St. Louis, MO 63110. E-mail: rrao/at/im.wustl.edu Authors’ addresses: Ramakrishna U. Rao, Laura J. Atkinson, and Gary J. Weil, Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, E-mails: rrao/at/wustl.edu, gweil/at/im.wustl.edu, and lja836/at/yahoo.com. Reda M. R. Ramzy, Hanan Helmy, and Hoda A. Farid, Research & Training Center on Vectors of Diseases, Ain Shams University, Abbassia, Cairo 11566, Egypt, E-mails: reda_m/at/masrawy.com, helmy26_2000/at/yahoo.com, and hafarid/at/rtcasuegypt.org. Moses J. Bockarie, Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea, and the Center for Global Health and Diseases, Case-Western Reserve University, Cleveland, OH 44106, E-mail: moses.bockarie/at/case.edu. Melinda Susapu, Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea, E-mail: msusapu/at/datec.net.pg. Sandra J. Laney and Steven A. Williams, Department of Biological Sciences, Smith College, Northampton, MA 01063. E-mails: slaney/at/smith.edu and swilliam/at/smith.edu. The publisher's final edited version of this article is available free at Am J Trop Med Hyg. See other articles in PMC that cite the published article.Abstract We developed and evaluated real-time polymerase chain reaction (PCR) assays for detecting Wuchereria bancrofti DNA in human blood and in mosquitoes. An assay based on detection of the W. bancrofti “LDR” repeat DNA sequence was more sensitive than an assay for Wolbachia 16S rDNA. The LDR-based assay was sensitive for detecting microfilarial DNA on dried membrane filters or on filter paper. We also compared real-time PCR with conventional PCR (C-PCR) for detecting W. bancrofti DNA in mosquito samples collected in endemic areas in Egypt and Papua New Guinea. Although the two methods had comparable sensitivity for detecting filarial DNA in reference samples, real-time PCR was more sensitive than C-PCR in practice with field samples. Other advantages of real-time PCR include its high-throughput capacity and decreased risk of cross-contamination between test samples. We believe that real-time PCR has great potential as a tool for monitoring progress in large-scale filariasis elimination programs. INTRODUCTION Bancroftian filariasis (caused by the nematode parasite Wuchereria bancrofti) is a serious tropical disease that can lead to chronic, disabling conditions such as lymphedema, elephantiasis, and genital deformities. Microscopy has been used since the time of Manson in the 19th century to show microfilariae in human blood and to detect filarial larvae in mosquitoes.1 Recent diagnostic advances in lymphatic filariasis (LF) have included development of sensitive immunoassays for detecting parasite antigens or antibodies in human blood2,3 and methods for detecting parasite DNA in blood and mosquitoes.4–15 These advances are timely in view of the diagnostic needs of the Global Program for Elimination of Lymphatic Filariasis (GPELF), which aims to eliminate filariasis as a public health problem in 83 countries by the year 2020.16–18 GPELF has relied heavily on antigen detection as a method for identifying and mapping areas to be targeted for mass drug administration (MDA). Other tools are needed to effectively monitor the effect of MDA programs and to determine whether filariasis transmission has been interrupted. Preliminary studies have shown the potential value of molecular xenodiagnosis (MX, detection of parasite DNA in mosquitoes by polymerase chain reaction [PCR]) as a tool for assessing changes in parasite prevalence rates in endemic populations after MDA.13 This method requires collection of representative samples of mosquitoes, efficient isolation of total DNA from mosquito pools, amplification of parasite DNA sequences, and detection of the amplified product. A number of groups have reported success using species-specific primers and PCR to amplify a 188-bp non-coding DNA sequence in W. bancrofti (the “SspI” repeat DNA sequence).4–6 The amplified product can be detected by agarose gel electrophoresis, enzyme-linked immunosorbent assay (ELISA), or by DNA test strips.4,13,19 Despite the potential value of this technology, MX has not been a practical choice for use by endemic countries for monitoring filariasis elimination programs; no government’s national filariasis elimination program uses this method for monitoring at this time. The main barrier to widespread adoption of this technology has been that the laboratory infrastructure required for the test is not widely available in filariasis-endemic countries. Technical barriers also should be mentioned. Current methods for MX are inefficient and labor-intensive, and in practice, testing is slow. Therefore, additional work is needed to further simplify MX for filariasis so that it can be a viable, practical tool for monitoring large filariasis elimination programs. With these goals in mind, the purpose of this study was to explore the use of real-time PCR for detecting filarial DNA. We performed preliminary studies with several target sequences to optimize the real-time PCR assays, and we evaluated the performance of these tests with several types of field samples. MATERIALS AND METHODS Detection of microfilaremia and filarial antigenemia Blood samples were collected in the Egyptian villages of Tahoria (TH, in Qalubyia governorate) and Kafr El Bahary (KB; Giza governorate). Approximately 10% of the households were studied each year in each village; different randomly selected household samples (~500 people per village) were studied each year. These repeated, cross-sectional surveys were performed before the first round of MDA and approximately 7–9 months after each round of MDA. Finger prick blood samples were collected for detection of W. bancrofti antigenemia with rapid-format card tests. Subjects with positive filariasis antigen tests were tested for microfilaremia by membrane filtration of 1 mL of venous blood collected between 9:00 pm and 1:00 am. The MF prevalence rate was defined as the number of people with microfilaremia divided by the number of people tested for filarial antigenemia. DNA isolation Wuchereria bancrofti DNA was recovered from dried nucleopore membranes (5-μm pore size; Nucleopore, Pleasanton, CA) that had been used to filter venous blood from humans with microfilaremia. DNA isolated from these filters is assumed to be largely parasite DNA with some human DNA from cells trapped on the filters. Genomic DNA (gDNA) was extracted using Wizard Genomic DNA kits (Promega, Madison, WI) into 200 μL of water as per the manufacturer’s instructions. The quality and quantity of gDNA was assessed by spectrophotometry (GeneQuant; Pharmacia Biotech, Cambridge, UK). The Wizard Kit was also used to isolate DNA from Dirofilaria immitis and Brugia malayi adult worms and from uninfected Aedes aegypti mosquitoes. DNA was also extracted from dried blood in sample application pads from used filarial antigen card tests (ICT Filariasis; AMRAD ICT, French’s Forest, NSW, Australia; and Filariasis Now kits; Binax, Portland, ME). These cards were selected from tests performed in Egypt during the years 2000–2004. Sample application pads contain cells and microfilariae (when present) from 100-μL blood samples. All blood samples were collected between 9:00 pm and 1:00 am. We also studied sample application pads from cards that had been tested with plasma instead of whole blood. Individual pads were carefully lifted off of the cards with sterile surgical blades. To avoid contamination, new blades were used for each pad. Total gDNA was extracted from these pads using QIAamp DNA kits (Qiagen, Valencia, CA). Mosquito collection and DNA extraction Methods used for collection of blood-engorged Culex pipiens from randomly selected houses in filariasis-endemic areas in Egypt have been previously described.5,14,19 Cx. pipiens mosquitoes were collected from approximately 100 randomly selected houses per village in KB and TH villages in Egypt in 2000 and 2003. The 2000 collection was performed before any MDA for filariasis. The 2003 collection was performed approximately 9 months after the third annual round of the Egyptian government’s MDA program (single dose diethylcarbamazine and albendazole with coverage of ~85% of the eligible population, which excluded children less than 2 years of age and pregnant women). Mosquitoes were tested by household pool with 5 to 25 mosquitoes per pool. Anopheles punctulatus mosquitoes were collected from villages in a filariasis-endemic area in Papua New Guinea (Usino-Bundi district in Madang province) using CDC light traps without CO2 placed inside houses. Mosquitoes were collected from three villages (Buksak, Iguruwe, and Naru). Female mosquitoes were sorted into two separate pools (engorged or gravid versus host-seeking) from each collection site. One hundred sixty-two mosquito pools from Papua New Guinea were tested in this study. The mean number of mosquitoes per pool was 7.4 (median, 4.5; range, 1–22). Genomic DNA was isolated from mosquitoes in Egypt and Papua New Guinea as previously described.11 These samples were tested in the endemic country laboratories for W. bancrofti DNA with conventional PCR, and aliquots of the DNA samples were coded and sent to St. Louis for blinded testing by real-time PCR. Real-time PCR assays for detection of W. bancrofti and Wolbachia DNA Preliminary studies showed that NV1 and NV2 primers used for amplification of the SspI target sequence by conventional PCR were not suitable for the real-time PCR assay.6 We proceeded to develop real-time PCR assays based on two other target sequences. The first of these, the “long DNA repeat” of W. bancrofti (LDR; GenBank accession no. AY297458) was used as a detection target with blood and mosquito gDNA templates. The second target studied was 16S rDNA (GenBank accession no. AF093510) from Wolbachia endosymbiont bacteria present in filarial worms.20 Conditions were optimized to amplify the LDR and Wolbachia 16S rDNA targets with primers and probes specific for these sequences. The primers (LDR1, LDR2) and TaqMan probe designed by Primer Express software (Applied Biosystems, Foster City, CA) for the LDR target sequence are shown in Figure 1
C-PCR assay to detect Wuchereria bancrofti DNA in mosquitoes C-PCR for detection of the SspI repeat DNA (Gen-Bank accession no. L20344) was performed in endemic country laboratories in Egypt and Papua New Guinea essentially as previously described.6 Briefly, this method uses primers NV1 and NV2 to amplify a 188-bp product in gDNA from W. bancrofti (Figure 1 Detection of W. bancrofti microfilariae in night blood samples Blood was collected by finger prick from consenting volunteers between 9:00 pm and 1:00 am. Microfilariae were detected by microscopic examination of Giemsa-stained 50-μL-thick smears. In some cases, MFs were detected by nucleopore membrane filtration of 1 mL venous blood.5 Ethical clearance Studies involving human subjects were reviewed and approved by institutional review boards at Washington University School of Medicine and at Ain Shams University. Informed consent was obtained from all participants. Data analysis The relationship between MF counts by membrane filter and Ct values was assessed by the non-parametric Spearman rank correlation test. RESULTS Detection of W. bancrofti and Wolbachia DNA using real-time PCR Preliminary technical studies were performed with serial dilutions of gDNA obtained from MF-positive membrane filters. Ct values obtained with the LDR primers and probe were inversely proportional to the amounts of DNA template tested, and reaction efficiencies were close to 100% (slope, −3.56; R2 = 0.98; Figure 2
Real-time PCR results obtained with primers and probes specific for the LDR and Wolbachia 16S rDNA target sequences for template from 19 MF-positive membrane filters are shown in Figure 3
Specificity of W. bancrofti DNA detection by real-time PCR To assess the specificity of real-time PCR, 10 and 1 ng of gDNA from human blood, Ae. aegypti mosquitoes, D. immitis adult worms, B. malayi adult worms, and W. bancrofti MF were used as templates for real-time PCR with the LDR primers and probe. Only the gDNA from W. bancrofti MF produced positive signals. Thus, this assay is specific for W. bancrofti DNA. Real-time PCR with primers and probe for Wolbachia 16S rDNA produced positive signals with templates containing W. bancrofti and B. malayi DNA but not E. coli DNA, indicating the assay is specific for Wolbachia DNA. Sensitivity of real-time PCR for detecting W. bancrofti DNA in dried blood from filariasis antigen card tests Forty-seven of 193 card test sample application pads with dried blood were positive for W. bancrofti DNA by real-time PCR with LDR reagents (Table 1). Parasite DNA was detected in all 33 samples from subjects with microfilaremia (100%) and in 14 of 70 (20%) sample pads from amicrofilaremic subjects with positive filarial antigen tests. Presumably, some of these subjects had low-level microfilaremia that was not detected by microscopic examination of stained thick blood smears. No parasite DNA was detected in 90 sample application pads from subjects with negative tests for microfilaremia and filarial antigenemia. In addition, no parasite DNA was detected in 12 sample application pads from MF-positive subjects whose antigen card tests had been performed with plasma instead of blood. Thus, we found no evidence of free parasite DNA in plasma from MF carriers.
DNA from all of the dried blood samples that had W. bancrofti DNA (detected by real-time PCR with LDR reagents) were retested by real-time PCR with the Wolbachia 16S rDNA primers and probe. Only 7 of 47 (14.8%) of these samples were positive for Wolbachia DNA. This confirmed the lower sensitivity of the Wolbachia-based assay relative to the LDR assay. Sensitivity of real-time PCR and C-PCR for detecting W. bancrofti DNA in Cx. pipiens and An. punctulatus mosquitoes Mosquito results are shown in Table 2. Real-time PCR (with LDR reagents) detected many more positive pools than C-PCR. All samples with discordant results were retested by both methods. All real-time PCR results were confirmed. However, many samples that were initially scored as negative by C-PCR and positive by real-time PCR were found to be positive by C-PCR after repeat testing; agreement between the two methods was fairly good when results of repeat C-PCR are considered.
Effects of MDA on mosquito infection rates Figure 4
DISCUSSION The purpose of this study was to explore the value of real-time PCR for detecting filarial DNA in field samples. A recent publication from Thailand showed that filarial DNA could be detected by real-time PCR with two probes and melting curve analysis.21 However, the authors did not report results of specificity testing or results obtained with field samples. In contrast to results reported by Lulitanond et al.,21 our preliminary studies showed that real-time PCR did not work well with NV1 and NV2 primers and a TaqMan probe directed to the SspI target sequence used for C-PCR. Therefore, we focused on studies to optimize conditions for detecting parasite DNA using the LDR and Wolbachia 16S target sequences. Our results showed that the LDR assay was sensitive, specific, and efficient, with a dose–response curve that was linear over a range of five orders of magnitude. We then evaluated the LDR detection assay with a panel of DNA samples isolated from membrane filters with known numbers of W. bancrofti MF visualized by microscopy. It was impressive that all membranes produced positive DNA signals after storage for periods ranging from 6 months to 4 years. LDR Ct values were significantly (inversely) correlated with MF counts, but the correlation was only moderately strong. This may reflect partial degradation of parasite DNA on old membranes, variable recovery of parasite DNA from membranes, or the possible presence of PCR inhibitors on membranes. The LDR real-time PCR assay was also sensitive for detecting parasite DNA in human blood dried on used ICT card sample application pads. Indeed, PCR detection was more sensitive for detecting infections than microscopy performed with blood from the same subjects, because some samples from amicrofilaremic subjects with positive filarial antigen tests had positive DNA tests. Specificity was excellent; positive tests were not seen with blood samples from amicrofilaremic subjects with negative antigen tests or with blood samples from MF carriers that was collected during the day. The latter result suggests that DNA detected by PCR is derived from intact MF and not from “free DNA” in plasma. The card test results suggest multiple new uses for these cards when they are tested with blood samples collected at times that correspond to peak MF levels. First, selected samples can be tested by real-time PCR to determine whether subjects with positive antigen tests have circulating MF. Second, used cards from different places and times provide a valuable archive of parasite DNA that may be useful for DNA-based studies of drug resistance or parasite polymorphism. The sensitivity of real-time PCR for detection of Wolbachia 16S DNA was much lower than the LDR assay for detecting filarial DNA. If the two reactions are equally efficient, the difference in Ct values (~10 cycles) suggests at least a 1,000-fold difference in copy number per cell for the two target sequences. Differences in stability of eukaryotic and bacterial DNA sequences on dried filters or differences in efficiency of isolation of DNA template from the parasite and bacteria may have contributed to the difference in sensitivity.22–24 While the number of LDR repeats in W. bancrofti gDNA presumably is constant throughout the parasite life cycle, this may not be the case for the Wolbachia target sequence. Recently, it has been reported that microfilariae have fewer Wolbachia than other parasite stages.25 This would tend to limit the diagnostic value of Wolbachia DNA for detecting MF in blood samples. Our project used large panels of mosquito DNA extracts from Egypt and Papua New Guinea to compare the sensitivity of real-time PCR (LDR target) with C-DNA (SspI target). The two methods had the same sensitivity with a standard template of isolated parasite DNA in our laboratory in St. Louis. However, the real-time PCR assay was more sensitive for detecting W. bancrofti DNA in field samples relative to C-PCR performed in endemic country laboratories. This evaluation provided a useful, real-world comparison of the two DNA detection methods. In practice, C-PCR requires subjective scoring of bands in agarose gels, and we found that technicians had been reluctant to score very faint or questionable bands as positives. Repeat C-PCR resolved discrepancies in most cases. However, there were a few cases where repeated testing verified discrepancies with some samples only positive by LDR real-time PCR and (a few) others only positive by C-PCR for the SspI sequence. Additional studies are needed to determine whether variability in LDR and SspI repeat sequences account for these discrepancies. Beyond the technical comparison of the two DNA detection methods, the decreases in Egyptian mosquito pool infection rates documented by LDR real-time PCR after MDA were impressive and consistent with C-PCR results. These results suggest that MDA had a major effect on parasite prevalence rates in the Egyptian villages studied, and they show the potential value of real-time PCR for monitoring the impact of MDA in filariasis elimination programs. Looking ahead to practicalities, we should point out that real-time PCR is comparable in cost to C-PCR (~$2 per mosquito pool including DNA isolation, target amplification, and detection of amplified product). Costs for the instrumentation and reagents for real-time PCR are decreasing over time; additional research is needed to further optimize methods to reduce costs. However, in terms of the data produced, MX by real-time PCR or C-PCR is far preferable (more sensitive and efficient) to traditional dissection with microscopy for detecting filarial infections in mosquito populations and as a tool for monitoring late stages of filariasis elimination programs. In comparing real-time PCR with C-PCR for this purpose, we favor real-time PCR because of its increased sensitivity with field samples, lower labor requirements, reduced potential for contamination in the laboratory (no need to separately analyze PCR products in the laboratory), and much higher throughput capability. Coupled with advances in mosquito collection methods and methods for DNA isolation, we believe that MX by real-time PCR (perhaps in regional reference laboratories) will prove to be a practical tool for monitoring filariasis elimination programs. Acknowledgments The authors would like to acknowledge the efforts of field teams and technical staff at Ain Shams University, Cairo, Egypt, and at the Papua New Guinea Institute of Medical Research in Madang. We thank K. Curtis for technical help. Financial support: This work was supported by National Institutes of Health Grant AI 35855. References 1. Grove DI, Warren KS, Mahmoud AA. Algorithms in the diagnosis and management of exotic diseases. VI. The filariases. J Infect Dis. 1975;132:340–352. [PubMed] 2. Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today. 1997;13:401–404. [PubMed] 3. Lammie P, Weil G, Rahmah N, Kaliraj P, Steel C, Goodman D, Lakshmikanthan V, Ottesen E. Recombinant antigen based assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria J. 2004;3:9. [PubMed] 4. Williams S, Laney S, Bierwert L, Saunders L, Boakye D, Fischer P, Goodman D, Helmy H, Hoti S, Vasuki V, Lammie P, Plichart C, Ramzy R, Ottesen E. Development and standardization of a rapid PCR-based method for the detection of Wuchereria bancrofti in mosquitoes for xenomonitoring the human prevalence of bancroftian filariasis. Ann Trop Med Parasitol. 2002;96:S41–S46. [PubMed] 5. Ramzy R, Farid H, Kamal H, Ibrahim G, Morsy Z, Faris R, Weil G. A polymerase chain reaction-based assay for detection of Wuchereria bancrofti in human blood and Culex pipiens. Trans Roy Soc Trop Med Hyg. 1997;91:156–160. [PubMed] 6. Zhong M, McCarthy J, Bierwert L, Lizotte-Waniewski M, Chanteau S, Nutman T, Ottesen E, Williams S. A polymerase chain reaction assay for detection of the parasite Wuchereria bancrofti in human blood samples. Am J Trop Med Hyg. 1996;54:357–363. [PubMed] 7. McCarthy J, Zhong M, Gopinath R, Ottesen E, Williams S, Nutman T. Evaluation of a polymerase chain reaction-based assay for diagnosis of Wuchereria bancrofti infection. J Infect Dis. 1996;173:1510–1514. [PubMed] 8. Fischer P, Liu X, Lizotte-Waniewski M, Kamal I, Ramzy R, Williams S. Development of a quantitative, competitive polymerase chain reaction-enzyme-linked immunosorbent assay for the detection of Wuchereria bancrofti DNA. Parasit Res. 1999;85:176–183. 9. Abbasi I, Hamburger J, Githure J, Ochola J, Agure R, Koech D, Ramzy R, Gad A, Williams S. Detection of Wuchereria bancrofti DNA in patients sputum by the polymerase chain reaction. Trans Roy Soc Trop Med Hyg. 1996;90:531–532. [PubMed] 10. Kluber S, Supali T, Williams SA, Liebau E, Fischer P. Rapid PCR-based detection of Brugia malayi DNA from blood spots by DNA detection test strips. Trans R Soc Trop Med Hyg. 2001;95:169–170. [PubMed] 11. Bockarie MJ, Fischer P, Williams SA, Zimmerman PA, Griffin L, Alpers MP, Kazura JW. Application of a polymerase chain reaction-ELISA to detect Wuchereria bancrofti in pools of wild-caught Anopheles punctulatus in a filariasis control area in Papua New Guinea. Am J Trop Med Hyg. 2000;62:363–367. [PubMed] 12. Chanteau S, Luquiaud P, Failloux AB, Williams SA. Detection of Wuchereria bancrofti larvae in pools of mosquitoes by the polymerase chain reaction. Trans R Soc Trop Med Hyg. 1994;88:665–666. [PubMed] 13. Goodman DS, Orelus JN, Roberts JM, Lammie PJ, Streit TG. PCR and Mosquito dissection as tools to monitor filarial infection levels following mass treatment. Filaria J. 2003;2:11. [PubMed] 14. Farid HA, Hammad RE, Hassan MM, Morsy ZS, Kamal IH, Weil GJ, Ramzy RM. Detection of Wuchereria bancrofti in mosquitoes by the polymerase chain reaction: a potentially useful tool for large-scale control programmes. Trans R Soc Trop Med Hyg. 2001;95:29–32. [PubMed] 15. Vasuki V, Hoti SL, Sadanandane C, Jambulingam P. A simple and rapid DNA extraction method for the detection of Wuchereria bancrofti infection in the vector mosquito, Culex quinquefasciatus by Ssp I PCR assay. Acta Trop. 2003;86:109–114. [PubMed] 16. Molyneux D. Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity. Filaria J. 2003;2:13. [PubMed] 17. Ottesen EA. Major progress toward eliminating lymphatic filariasis. N Engl J Med. 2002;347:1885–1886. [PubMed] 18. World Health Organization. Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec. 2005;80:202–212. [PubMed] 19. Helmy H, Fischer P, Farid HA, Bradley MH, Ramzy RM. Test strip detection of Wuchereria bancrofti amplified DNA in wild-caught Culex pipiens and estimation of infection rate by a PoolScreen algorithm. Trop Med Int Health. 2004;9:158–163. [PubMed] 20. Taylor MJ, Bilo K, Cross HF, Archer JP, Underwood AP. 16S rDNA phylogeny and ultrastructural characterization of Wolbachia intracellular bacteria of the filarial nematode Brugia malayi, B. pahangi, and Wuchereria bancrofti. Exp Parasitol. 1999;91:356–361. [PubMed] 21. Lulitanond V, Intapan PM, Pipitgool V, Choochote W, Maleewong W. Rapid detection of Wuchereria bancrofti in mosquitoes by LightCycler polymerase chain reaction and melting curve analysis. Parasitol Res. 2004;94:337–341. [PubMed] 22. Farkas DH, Drevon AM, Kiechle FL, DiCarlo RG, Heath EM, Crisan D. Specimen stability for DNA-based diagnostic testing. Diagn Mol Pathol. 1996;5:227–235. [PubMed] 23. Solomon AW, Holland MJ, Burton MJ, West SK, Alexander ND, Aguirre A, Massae PA, Mkocha H, Munoz B, Johnson GJ, Peeling RW, Bailey RL, Foster A, Mabey DC. Strategies for control of trachoma: observational study with quantitative PCR. Lancet. 2003;362:198–204. [PubMed] 24. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 1993;362:709–715. [PubMed] 25. McGarry HF, Egerton GL, Taylor MJ. Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayi. Mol Biochem Parasitol. 2004;135:57–67. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
J Infect Dis. 1975 Sep; 132(3):340-52.
[J Infect Dis. 1975]Parasitol Today. 1997 Oct; 13(10):401-4.
[Parasitol Today. 1997]Filaria J. 2004 Sep 3; 3(1):9.
[Filaria J. 2004]Ann Trop Med Parasitol. 2002 Dec; 96 Suppl 2():S41-6.
[Ann Trop Med Parasitol. 2002]Acta Trop. 2003 Apr; 86(1):109-14.
[Acta Trop. 2003]Filaria J. 2003 Jul 7; 2(1):11.
[Filaria J. 2003]Ann Trop Med Parasitol. 2002 Dec; 96 Suppl 2():S41-6.
[Ann Trop Med Parasitol. 2002]Am J Trop Med Hyg. 1996 Apr; 54(4):357-63.
[Am J Trop Med Hyg. 1996]Trop Med Int Health. 2004 Jan; 9(1):158-63.
[Trop Med Int Health. 2004]Trans R Soc Trop Med Hyg. 1997 Mar-Apr; 91(2):156-60.
[Trans R Soc Trop Med Hyg. 1997]Trans R Soc Trop Med Hyg. 2001 Jan-Feb; 95(1):29-32.
[Trans R Soc Trop Med Hyg. 2001]Trop Med Int Health. 2004 Jan; 9(1):158-63.
[Trop Med Int Health. 2004]Am J Trop Med Hyg. 2000 Mar; 62(3):363-7.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 1996 Apr; 54(4):357-63.
[Am J Trop Med Hyg. 1996]Exp Parasitol. 1999 Apr; 91(4):356-61.
[Exp Parasitol. 1999]Am J Trop Med Hyg. 1996 Apr; 54(4):357-63.
[Am J Trop Med Hyg. 1996]Trans R Soc Trop Med Hyg. 1997 Mar-Apr; 91(2):156-60.
[Trans R Soc Trop Med Hyg. 1997]Parasitol Res. 2004 Nov; 94(5):337-41.
[Parasitol Res. 2004]Parasitol Res. 2004 Nov; 94(5):337-41.
[Parasitol Res. 2004]Diagn Mol Pathol. 1996 Dec; 5(4):227-35.
[Diagn Mol Pathol. 1996]Nature. 1993 Apr 22; 362(6422):709-15.
[Nature. 1993]Mol Biochem Parasitol. 2004 May; 135(1):57-67.
[Mol Biochem Parasitol. 2004]